Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Collegium Pharmaceutical
COLL
5
Enerpac Tool
EPAC
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 42.34%2.38B | 23.37%14.78B | 17.05%4.83B | 58.86%5.14B | 16.31%3.14B | -12.87%1.67B | 7.01%11.98B | 33.23%4.13B | -16.16%3.23B | 9.81%2.7B |
Net income from continuing operations | 8.93%3.28B | 15.00%12.87B | 19.74%3.34B | 2.03%3.26B | 14.52%3.26B | 27.53%3.01B | 12.74%11.2B | 10.53%2.79B | 27.97%3.2B | 25.05%2.85B |
Operating gains losses | 583.33%29M | -52.46%29M | -17.65%-40M | 933.33%62M | 110.57%13M | -102.83%-6M | -57.93%61M | -383.33%-34M | 110.00%6M | -205.13%-123M |
Depreciation and amortization | 27.31%275M | 12.27%897M | 12.68%231M | 6.64%225M | 17.19%225M | 13.09%216M | 6.53%799M | 11.41%205M | 14.05%211M | 1.59%192M |
Deferred tax | 1,133.33%37M | -123.31%-527M | -8,966.67%-266M | 36.12%-168M | -162.75%-96M | 102.33%3M | 63.75%-236M | 104.84%3M | -113.82%-263M | 204.79%153M |
Other non cash items | 16.03%514M | 22.93%2.02B | 60.00%576M | 15.91%539M | 5.47%463M | 16.58%443M | 0.86%1.64B | -8.40%360M | 14.25%465M | 11.14%439M |
Change In working capital | 10.41%-1.88B | 46.47%-1.04B | 22.81%883M | 305.83%1.06B | 6.68%-880M | -74.67%-2.1B | -114.93%-1.94B | 2,665.38%719M | -160.59%-515M | -98.95%-943M |
-Change in receivables | 46.12%-118M | 102.93%21M | 66.52%-78M | 254.17%333M | 93.48%-15M | -476.32%-219M | -52.88%-717M | -62.94%-233M | -213.04%-216M | 41.18%-230M |
-Change in prepaid assets | 2.15%-1.46B | -32.28%-3.23B | 25.29%-449M | -44.46%-796M | 6.67%-490M | -95.80%-1.49B | -12.09%-2.44B | 14.51%-601M | -25.51%-551M | 11.32%-525M |
-Change in payables and accrued expense | 1.52%-585M | 5,425.00%1.7B | 19.42%1.03B | 988.89%1.27B | 97.30%-9M | 12.78%-594M | -102.14%-32M | 23.40%865M | -89.39%117M | -161.90%-333M |
-Change in other current assets | 29.02%-296M | -1,582.50%-593M | 235.14%150M | -277.22%-459M | 193.01%133M | -1,291.43%-417M | -16.67%40M | 55.60%-111M | 502.33%259M | -486.49%-143M |
-Change in other current liabilities | -71.16%124M | 226.95%922M | -52.37%191M | 454.67%532M | -184.93%-231M | 278.42%430M | 40.30%282M | 629.09%401M | -138.96%-150M | 114.17%272M |
-Change in other working capital | 140.11%449M | -85.79%131M | -90.95%36M | 576.92%176M | -1,775.00%-268M | -61.20%187M | 15,466.67%922M | 8.74%398M | 115.03%26M | 108.29%16M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 42.34%2.38B | 23.37%14.78B | 17.05%4.83B | 58.86%5.14B | 16.31%3.14B | -12.87%1.67B | 7.01%11.98B | 33.23%4.13B | -16.16%3.23B | 9.81%2.7B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -95.40%-340M | -151.81%-3.4B | -1,151.40%-2.68B | 50.96%-256M | -34.86%-294M | 56.17%-174M | 8.10%-1.35B | 38.86%-214M | -69.48%-522M | 58.48%-218M |
Capital expenditure reported | 10.41%-198M | -0.42%-720M | 19.27%-155M | -25.38%-163M | -18.30%-181M | 8.68%-221M | -9.47%-717M | 8.13%-192M | 21.69%-130M | -15.91%-153M |
Net PPE purchase and sale | -1.27%-159M | -27.76%-474M | -23.38%-95M | -2.88%-107M | -43.75%-115M | -42.73%-157M | 16.06%-371M | 40.77%-77M | 6.31%-104M | -45.45%-80M |
Net business purchase and sale | ---- | ---2.51B | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net investment purchase and sale | -93.40%14M | 219.07%306M | 808.33%85M | 104.55%13M | -125.00%-4M | 748.00%212M | -350.88%-257M | 14.29%-12M | -853.33%-286M | 206.67%16M |
Net other investing changes | 137.50%3M | 50.00%-3M | -102.99%-2M | 150.00%1M | 700.00%6M | 88.57%-8M | -100.00%-6M | 2,133.33%67M | -100.00%-2M | 90.00%-1M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -95.40%-340M | -151.81%-3.4B | -1,151.40%-2.68B | 50.96%-256M | -34.86%-294M | 56.17%-174M | 8.10%-1.35B | 38.86%-214M | -69.48%-522M | 58.48%-218M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -11.41%-2.99B | -14.21%-10.84B | -71.96%-4.04B | 64.35%-857M | -17.20%-3.26B | -37.14%-2.68B | 8.13%-9.49B | 34.98%-2.35B | -38.24%-2.4B | 1.49%-2.78B |
Net issuance payments of debt | --492M | 68.85%2.62B | --0 | 65,925.00%2.64B | -127.87%-17M | --0 | 289.47%1.55B | --0 | -98.59%4M | --61M |
Net common stock issuance | -27.96%-2.55B | -22.18%-11.04B | -89.41%-3.47B | -53.93%-2.93B | -9.23%-2.64B | 30.79%-1.99B | -3.19%-9.03B | 24.11%-1.83B | -22.89%-1.91B | -1.51%-2.42B |
Cash dividends paid | -12.66%-694M | -13.44%-2.45B | -13.48%-606M | -13.57%-611M | -13.68%-615M | -13.03%-616M | -13.40%-2.16B | -12.90%-534M | -13.50%-538M | -13.42%-541M |
Proceeds from stock option exercised by employees | -57.73%41M | -5.49%224M | 154.17%61M | 17.07%48M | -84.87%18M | 83.02%97M | 163.33%237M | 84.62%24M | 355.56%41M | 197.50%119M |
Net other financing activities | -62.94%-277M | -125.84%-201M | -225.00%-26M | 80.00%-1M | -100.00%-4M | -129.73%-170M | 44.72%-89M | 33.33%-8M | 28.57%-5M | 50.00%-2M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -11.41%-2.99B | -14.21%-10.84B | -71.96%-4.04B | 64.35%-857M | -17.20%-3.26B | -37.14%-2.68B | 8.13%-9.49B | 34.98%-2.35B | -38.24%-2.4B | 1.49%-2.78B |
Net cash flow | ||||||||||
Beginning cash position | 3.28%10.81B | 13.80%10.47B | 48.33%12.97B | 3.30%8.8B | 4.40%9.19B | 13.80%10.47B | -7.13%9.2B | -10.58%8.74B | 4.53%8.52B | -4.50%8.8B |
Current changes in cash | 19.95%-947M | -52.50%542M | -220.37%-1.89B | 1,210.42%4.02B | -38.13%-413M | -173.21%-1.18B | 289.22%1.14B | 281.25%1.57B | -83.03%307M | 66.37%-299M |
Effect of exchange rate changes | 227.37%121M | -255.47%-199M | -274.52%-274M | 265.12%142M | 40.00%28M | -356.76%-95M | 224.27%128M | -44.72%157M | 53.51%-86M | 111.49%20M |
End cash Position | 8.65%9.98B | 3.28%10.81B | 3.28%10.81B | 48.33%12.97B | 3.30%8.8B | 4.40%9.19B | 13.80%10.47B | 13.80%10.47B | -10.58%8.74B | 4.53%8.52B |
Free cash flow | 56.34%2.02B | 24.73%13.59B | 18.73%4.58B | 62.25%4.87B | 15.29%2.84B | -17.42%1.29B | 7.86%10.89B | 39.84%3.86B | -16.21%3B | 8.59%2.47B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |